ReposiTrak (TRAK) Q2 2025 earnings summary

Executive summary

• Achieved 7% year-over-year revenue growth for the quarter and six-month period, driven by recurring subscription gains across traceability, compliance, and supply chain segments.

• Net income for the quarter increased to $1.55 million, up 12% year-over-year; six-month net income rose to $3.2 million, up 14%.

• Deferred revenue surged 70% since June 2024, reflecting strong future subscription growth and onboarding ahead of FSMA 204 deadlines.

• Cash and cash equivalents reached $28 million, up 11%, with no bank debt and continued capital returns via dividends, buybacks, and preferred redemptions.

• Board approved a 10% increase in the quarterly dividend, effective December 2024.

Financial highlights

• Q2 FY25 revenue was $5.5 million (up 7%); six-month revenue reached $11 million (up 7.3%).

• Quarterly net income was $1.55 million; six-month net income was $3.2 million.

• EPS for the quarter was $0.08 (basic and diluted); six-month EPS was $0.17 (basic), $0.16 (diluted), up 21% year-over-year.

• Cash from operations for the six months was $5.3 million, up 117% year-over-year.

• Operating margin improved, with income from operations at $1.35 million for the quarter.

Outlook and guidance

• Management expects double-digit revenue growth in the second half of FY25 and into FY26, targeting 10%-20% top-line growth for the full year.

• Profitability is expected to outpace revenue growth due to fixed cost structure and operational leverage.

• Deferred revenue and onboarding of 5,500 facilities expected to add nearly $10 million in annualized revenue over 24 months.

• Existing cash and operating cash flow are sufficient to fund operations and investments for at least the next twelve months.